Optimum combination of targeted 131I and total body irradiation for treatment of disseminated cancer
- 15 June 1995
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 32 (3) , 713-721
- https://doi.org/10.1016/0360-3016(94)00497-9
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Radiobiological modeling of combined targeted 131I therapy and total body irradiation for treatment of disseminated tumors of differing radiosensitivityInternational Journal of Radiation Oncology*Biology*Physics, 1993
- 131I-meta-iodobenzylguanidine therapy in neuroblastoma spheroids of different sizesBritish Journal of Cancer, 1992
- Tumour size dependence of relative efficacy of radioimmunotherapy and external beam irradiation in tumour treatmentRadiotherapy and Oncology, 1992
- Optimum combination of targeted131I therapy and total-body irradiation for treatment of disseminated tumors of differing radiosensitivityCell Biochemistry and Biophysics, 1992
- Published by Springer Nature ,1991
- International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma.Journal of Clinical Oncology, 1988
- The biodistribution and pharmacokinetics of meta-iodobenzylguanidine in childhood neuroblastomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 1988
- Intrinsic radiosensitivity of human cell lines is correlated with radioresponsiveness of human tumors: Analysis of 101 published survival curvesInternational Journal of Radiation Oncology*Biology*Physics, 1985
- The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapyThe British Journal of Radiology, 1985
- Dose fractionation, dose rate and iso-effect relationships for normal tissue responsesInternational Journal of Radiation Oncology*Biology*Physics, 1982